New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
D002439:Cefotaxime / Q000494:pharmacology; D002442:Ceftazidime; D002511:Cephalosporins / Q000494:pharmacology*; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006801:Humans; D009070:Moxalactam / Q000494:pharmacology; D014031:Tobramycin / Q000494:pharmacology
D002511:Cephalosporins; D002442:Ceftazidime; D002439:Cefotaxime; D009070:Moxalactam; D014031:Tobramycin